Patients’ responses to oncologists can help predict survival in chronic lymphocytic leukemia
Patients’ responses to questions routinely raised by oncologists may provide important clues about their chances of survival from…
New study uncovers metabolic vulnerability in high-risk myelodysplastic syndromes
Researchers at the University of Colorado Anschutz Cancer Center have identified a previously unknown metabolic weakness in the…
New gene signature predicts immunotherapy success for bone marrow cancers
A team led by researchers from the German Cancer Research Center (DKFZ), the HI-STEM Stem Cell Institute, and Medical…
Researchers find a new genetic vulnerability in acute myeloid leukemia
A study published in Nature Cell Biology reports a new vulnerability in acute myeloid leukemia (AML) that might…
Weight loss and anti-inflammatory drugs combine to combat leukemia
Obesity can act as fuel for leukemia, according to a study led by Indiana University School of Medicine…
Study explains how leukemia creates inflammatory lung environments
Acute myeloid leukemia (AML) does more than infiltrate the lungs: it also transforms lung tissue to create an…
How surviving leukemia changed Duke Health CEO’s approach to patient care :: WRAL.com
Dr. David Zaas is stepping into a new role on familiar grounds as the new CEO of Duke…
Roswell Park scientists present five key cancer studies at clinical meeting
The research findings of experts from Roswell Park Comprehensive Cancer Center will be featured during the American Society…
Small T-cell subset drives powerful multiple myeloma immunotherapy responses
Researchers from The University of Osaka find that only a small fraction of T cells may drive the…
Tip Sheet: Improving outcomes for stem cell transplants, exploring the link between solar jetlag and liver cancer — and expanding cancer treatment targets
Is there a way to boost immunotherapy response?
Molecular biologist Kevin Barry, PhD, received a $270,000, two-year grant…
OICR funds four Ontario teams to develop next-generation cancer therapies
Better cancer care depends on better treatment options. That’s why the Ontario Institute for Cancer Research (OICR) is…
Biomimetic platform enhances CAR T therapy for relapsed and refractory leukemia
Chimeric antigen receptor T (CAR T) cell therapy represents a milestone in leukemia treatment. CAR T works by…